Digital pathology assisted by AI has the potential to revolutionize the diagnosis and treatment of fibrotic liver disease. While not yet approved for routine clinical use, AI technology can provide more precise and quantitative analysis compared to traditional methods. AI tools can offer a more accurate assessment of fibrosis severity, enabling earlier detection and better monitoring of disease progression. Additionally, AI-assisted pathology can improve the consistency of diagnoses across different healthcare settings, leading to more effective clinical trials. The introduction of AI in pathology has the potential to enhance the performance of pathologists, standardize scoring, and ultimately improve patient care and outcomes.
Source link
AI-Assisted Pathology Poised to Transform Liver Disease Care
